351 related articles for article (PubMed ID: 18698221)
21. Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Tomiyoshi Y; Sakemi T; Aoki S; Miyazono M
Nephron; 2002 Dec; 92(4):860-7. PubMed ID: 12399633
[TBL] [Abstract][Full Text] [Related]
22. Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.
Ott IM; Alter ML; von Websky K; Kretschmer A; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Stasch JP; Hocher B
PLoS One; 2012; 7(8):e42623. PubMed ID: 22900035
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
Sengul AM; Altuntas Y; Kürklü A; Aydin L
Diabetes Res Clin Pract; 2006 Feb; 71(2):210-9. PubMed ID: 16112244
[TBL] [Abstract][Full Text] [Related]
24. d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.
Niibo M; Kanasaki A; Iida T; Ohnishi K; Ozaki T; Akimitsu K; Minamino T
PLoS One; 2022; 17(1):e0263300. PubMed ID: 35100325
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus.
Uehara Y; Hirawa N; Kawabata Y; Numabe A; Gomi T; Ikeda T; Omata M
Am J Hypertens; 1999 Jan; 12(1 Pt 1):21-7. PubMed ID: 10075380
[TBL] [Abstract][Full Text] [Related]
26. Renal protective effect of YM598, a selective endothelin type A receptor antagonist.
Sugimoto K; Fujimori A; Yuyama H; Tahara A; Fujimura A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S451-4. PubMed ID: 15838346
[TBL] [Abstract][Full Text] [Related]
27. Reduction of proteinuria with angiotensin receptor blockers.
Galle J
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
[TBL] [Abstract][Full Text] [Related]
28. Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril.
Sugimoto K; Tsuruoka S; Fujimura A
Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):601-7. PubMed ID: 10474773
[TBL] [Abstract][Full Text] [Related]
29. Telmisartan inhibits AGE-induced podocyte damage and detachment.
Fukami K; Yamagishi S; Kaifu K; Matsui T; Kaida Y; Ueda S; Takeuchi M; Asanuma K; Okuda S
Microvasc Res; 2013 Jul; 88():79-83. PubMed ID: 23648312
[TBL] [Abstract][Full Text] [Related]
30. Telmisartan in the management of diabetic nephropathy: a contemporary view.
Balakumar P; Bishnoi HK; Mahadevan N
Curr Diabetes Rev; 2012 May; 8(3):183-90. PubMed ID: 22429010
[TBL] [Abstract][Full Text] [Related]
31. Telmisartan in incipient and overt diabetic renal disease.
Schmieder RE; Bakris G; Weir MR
J Nephrol; 2011; 24(3):263-73. PubMed ID: 21374585
[TBL] [Abstract][Full Text] [Related]
32. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
Mazerska M; Myśliwiec M
Adv Med Sci; 2009; 54(1):37-40. PubMed ID: 19505872
[TBL] [Abstract][Full Text] [Related]
33. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
[TBL] [Abstract][Full Text] [Related]
34. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.
Kang KS; Yamabe N; Kim HY; Park JH; Yokozawa T
Biol Pharm Bull; 2010; 33(6):1077-81. PubMed ID: 20522983
[TBL] [Abstract][Full Text] [Related]
35. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
36. Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties.
Sugimoto K; Tsuruoka S; Fujimura A
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):826-30. PubMed ID: 11553023
[TBL] [Abstract][Full Text] [Related]
37. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
38. Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats.
Okumura M; Masada M; Yoshida Y; Shintaku H; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Imanishi M
Kidney Int; 2006 Aug; 70(3):471-6. PubMed ID: 16775605
[TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
[TBL] [Abstract][Full Text] [Related]
40. Retinal and choroidal vasculature in rats with spontaneous diabetes type 2 treated with the angiotensin-converting enzyme inhibitor cilazapril: corrosion cast and electron-microscopic study.
Bhutto IA; Lu ZY; Takami Y; Amemiya T
Ophthalmic Res; 2002; 34(4):220-31. PubMed ID: 12297695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
